Codes / ICD10CM / I70.549

I70.549 Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Atherosclerosis of Left Leg Bypass Graft with Ulceration
  • Medical Term: Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site
  • ICD-10 Code: I70.549

Summary

Atherosclerosis of nonautologous biological bypass graft(s) of the left leg with ulceration of unspecified site refers to plaque buildup in a biological graft (e.g., donor tissue) used to bypass blocked arteries in the left leg, accompanied by ulceration at an unspecified location. This narrowing reduces blood flow to the limb, potentially leading to tissue damage or complications if not managed. Nonautologous grafts are derived from sources other than the patient’s own body, such as donor veins or arteries.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. Over time, these deposits harden and narrow the vessel, restricting blood flow. The process is often linked to systemic atherosclerosis and may be accelerated by factors like inflammation or graft injury. Ulceration can occur when reduced blood flow leads to tissue breakdown.

Risk Factors

  • Age (more common in older adults)
  • History of cardiovascular disease
  • High cholesterol or triglyceride levels
  • Hypertension (high blood pressure)
  • Smoking or tobacco use
  • Diabetes or insulin resistance
  • Obesity or sedentary lifestyle
  • Poor diet (high in saturated fats, trans fats, or sodium)

Symptoms

  • Leg pain or cramping during activity (claudication)
  • Reduced pulse or coldness in the left leg
  • Visible ulceration (unspecified site)
  • Slow-healing wounds
  • Numbness or tingling in the leg
  • Skin discoloration or changes

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and vascular assessments. A physical exam may reveal reduced pulses, skin changes, or ulceration. Imaging such as Doppler ultrasound, angiography, or CT angiography can visualize graft narrowing or blockages. Laboratory tests may assess cholesterol, blood sugar, or inflammatory markers. Documentation of ulceration (unspecified site) and the nonautologous biological graft is critical for coding accuracy.

Treatment Options

Treatment focuses on managing atherosclerosis, improving blood flow, and promoting ulcer healing. Lifestyle modifications (e.g., smoking cessation, diet changes) and medications (e.g., statins, antiplatelet agents) may be used. Revascularization procedures (e.g., angioplasty, graft revision) or wound care for ulcers may be necessary. In severe cases, amputation could be considered.

Prognosis and Follow-Up

Prognosis depends on the extent of graft narrowing, ulcer severity, and response to treatment. Regular follow-up with vascular specialists is essential to monitor graft function and ulcer healing. Early intervention improves outcomes, but advanced disease may lead to limb-threatening complications.

Complications

  • Worsening ulceration or infection
  • Graft failure or occlusion
  • Limb ischemia or gangrene
  • Increased risk of amputation
  • Systemic cardiovascular events (e.g., heart attack, stroke)

Lifestyle & Prevention

  • Quit smoking or avoid tobacco use
  • Maintain a heart-healthy diet (low in saturated fats, high in fiber)
  • Exercise regularly (as tolerated) to improve circulation
  • Manage blood pressure, cholesterol, and blood sugar levels
  • Attend regular vascular check-ups

When to Seek Professional Help

Seek immediate care for:

  • Sudden severe leg pain or coldness
  • Non-healing or worsening ulceration
  • Signs of infection (e.g., redness, pus, fever)
  • Changes in skin color or sensation

Tips for Medical Coders

Document the presence of ulceration (unspecified site) and confirm the use of a nonautologous biological bypass graft in the left leg. Ensure clinical notes specify the graft type (biological, nonautologous) and the ulcer’s location (unspecified) to support accurate coding. Review operative reports or imaging for graft details and ulcer documentation.

Book a walkthrough

I70.549 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.